Sökning: "CD35"
Visar resultat 1 - 5 av 6 avhandlingar innehållade ordet CD35.
1. Feedback Enhancement of Antibody Responses via Complement and Fc Receptors
Sammanfattning : IgG, IgM and IgE in complex with antigen have the capacity to regulate specific immune responses. In this investigation, the role of Fc receptors for IgG (FcγRI, FcγRII and FcγRIII) and complement receptors 1 and 2 (CR1/2) for antibody-mediated enhancement of antibody responses are investigated. LÄS MER
2. Skin hydration - How water and osmolytes influence biophysical properties of stratum corneum
Sammanfattning : The outermost layer of skin (i.e., the stratum corneum, SC) is the interface that separates the water-rich inside of the body from the relatively dry external environment. SC forms an effective permeability barrier, which has to be overcome in transdermal drug delivery. LÄS MER
3. Computational Single-Cell Genomics Methods for Cell State Estimation and their Application to Hematopoietic Systems
Sammanfattning : The focus of this doctoral dissertation was to develop novel and scalable computational genomics methods for analysing single-cell genomic modalities. Scarf, a highly memory-efficient single-cell data analysis toolkit, was developed to enable an analysis of very large-scale datasets on personal computers, and the execution of parallel workflows on server-scale computational systems. LÄS MER
4. Neutrophil Chemotaxis and Respiratory Burst in Term and Preterm Newborn Infants
Sammanfattning : Neutrophil activation is the most important initial immune defense against invading microbes in newborn infants. The reduced neutrophil migration and uncontrolled regulation of reactive oxygen species (ROS) production observed in neonates, could result in a diminished infectious response or in tissue damage. LÄS MER
5. Somatostatin, dendritic cells and peptide T in psoriasis : a clinical, immunohistochemical and functional study
Sammanfattning : Peptide T is an octapeptide designed to block the CD4 receptor. In a phase 1 study 9 psoriasis patients were treated with 2 mg peptide T i.v. once daily for 28 days and followed for a further 3 months. LÄS MER